...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Why is agora deleting posts?? Was that last one to honest???

No e-mail no nothing - just gone??what goes on here?  

Share
New Message
Please login to post a reply